Profile picture

Mr Anders Holt

Herlev and Gentofte Hospital, Copenhagen (Denmark)
Membership: ESC Professional Member
Follow
Logo ESC

Contributor content

Trends and outcomes of direct oral anticoagulant use in patients with cancer: a nationwide cohort study
Presentation
Trends and outcomes of direct oral anticoagulant use in patients with cancer: a nationwide cohort study
Vagal activity related events and GLP-1 receptor agonists
Presentation
Vagal activity related events and GLP-1 receptor agonists
Beta-blocker side-effects in clinical practice: a nationwide approach
Presentation
Beta-blocker side-effects in clinical practice: a nationwide approach
Cardiovascular risk prediction in a New Zealand cohort of patients with known cardiovascular disease - a regional individual patient-level data linkage study
Presentation
Cardiovascular risk prediction in a New Zealand cohort of patients with known cardiovascular disease - a regional individual patient-level data linkage study
Long-term risk of cardiovascular side-effects following attention-deficit hyperactivity disorder treatment with sympathomimetic amines
Presentation
Long-term risk of cardiovascular side-effects following attention-deficit hyperactivity disorder treatment with sympathomimetic amines
Usage and risk with phosphodiesterase type 5 inhibitors in male patients with chronic ischemic heart disease on oral organic nitrates
Presentation
Usage and risk with phosphodiesterase type 5 inhibitors in male patients with chronic ischemic heart disease on oral organic nitrates
Gastrointestinal bleeding risk following concomitant treatment with oral glucocorticoids in patients with atrial fibrillation on direct-acting oral anticoagulants
Presentation
Gastrointestinal bleeding risk following concomitant treatment with oral glucocorticoids in patients with atrial fibrillation on direct-acting oral anticoagulants
Effect of beta blocker therapy following myocardial infarction  in optimally treated patients in the reperfusion era - a Danish, nationwide, and registry-based cohort study
Presentation
Effect of beta blocker therapy following myocardial infarction in optimally treated patients in the reperfusion era - a Danish, nationwide, and registry-based cohort study

ESC 365 is supported by